Roche defends diet drug as FDA probes liver claim

There is no evidence of a link between weight loss drug Xenical and liver injury, drugmaker Roche said on Tuesday.

United States health officials are reviewing reports of liver injury in people who took Xenical or the over-the-counter version of the drug sold by GlaxoSmithKline under the brand name alli.

The Food and Drug Administration (FDA) said on Monday it had received 32 reports between 1999 and 2008 of serious liver injury in patients taking the drug, which is known generically as orlistat.

”Roche has continually monitored and analysed the hepatic [liver] safety of Xenical. Up to now, there is no evidence of a link between Xenical and liver injury,” spokesperson Alexander Klauser said in a statement.

Neither treatment is a major revenue driver for Glaxo or Roche.

”Since Xenical is only to a minimal extent systemically absorbed, there is no obvious mechanism to explain hepatoxicity. However, we take patient safety very seriously and continue to work closely with the FDA,” Klauser said.

The safety of Xenical has been shown by more than 100 clinical studies including more than 30 000 patients, he added.

Glaxo also said late on Monday there was no evidence their drug caused liver damage. — Reuters

We make it make sense

If this story helped you navigate your world, subscribe to the M&G today for just R30 for the first three months

Subscribers get access to all our best journalism, subscriber-only newsletters, events and a weekly cryptic crossword.”

Related stories

WELCOME TO YOUR M&G

Already a subscriber? Sign in here

Advertising

Latest stories

Art imitates life at the National Arts Festival

This year’s National Arts Festival in Makhanda - the first live one since the pandemic - tackles unemployment, the Marikana Massacre and the manner in which black women in society are written about

Pride is a heavy price to pay

While constitutionally protected, the LGBTQIA+ community is being failed by the state

Africa’s Covid neglect poses global danger

Low vaccination levels and high number of health-compromised populations make the continent a ‘breeding ground for variants’ that pose a global risk

Kenya opposition leader selects woman as running mate

For the first time a woman is running on a major presidential ticket – a big marker in Kenya’s history. But for marginalised voters, the politics of representation comes with many contradictions
Advertising

press releases

Loading latest Press Releases…
×